PPHVanEck Vectors Pharmaceutical ETF
Fund Description
VanEck Vectors® Pharmaceutical ETF (PPH®) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
-
Fund Ticker
PPH -
Exchange
NASDAQ -
ETF Structure
Physical -
Administrator
Van Eck Associates -
Custodian
State Street Bank and Trust Company -
Index Ticker
MVPPHTR -
Index Rebalancing
Quarterly
as of 03/05/21
-
30-Day SEC Yield1
1.60% -
Total Net Assets
$183.6M -
Number of Holdings
25 -
Options
Available -
Gross Expense Ratio2
0.42% -
Net Expense Ratio/TER2
0.35% -
Distribution Frequency
Quarterly
Key Points
- Highly Liquid Companies
Index seeks to track the most liquid companies in the industry based on market capitalization and trading volume
- Industry Leaders
Index methodology favors the largest companies in the industry
- Global Scope
Portfolio may include both domestic and U.S. listed foreign companies, allowing for enhanced industry representation
Trading Information
-
Fund Ticker
PPH -
Index Total Return Ticker
MVPPHTR -
NAV
PPHNV -
Intraday NAV (IIV)4
PPHIV -
Shares Outstanding
2,738,138 -
Estimated Cash
PPHEU -
Total Cash
PPHTC -
CUSIP
92189F692 -
ISIN
US92189F6925
Fees and Expenses2
-
Management Fee
0.35% -
Other Expenses
0.07% -
Gross Expense Ratio
0.42% -
Fee Waivers andExpense Reimbursement
-0.07% -
Net Expense Ratio/TER2
0.35%
Investment Professionals
Peter Liao, CFA
- Portfolio Manager and Head of Equity ETFs
- Oversees the Equity ETF Investment Management Team including development and management of index replication and optimization strategies
- Joined VanEck in 2005
- CFA charterholder; member of the CFA Society New York
- BA, Mathematics and Economics, New York University
Guo Hua (Jason) Jin
- Portfolio Manager and Analyst for Equity ETFs
- Joined VanEck in 2007
- Prior to his current role, held a portfolio administration position at VanEck
- Previously, Portfolio Analyst at Evaluation Associates
- BS, Business Administration (concentration in Financial Analysis), State University of New York at Buffalo
Griffin Driscoll
- Analyst for Equity ETFs
- Joined VanEck in 2018
- Prior to joining VanEck, ETF Basket Operations Analyst at JPMorgan
- BS, Finance, Providence College
Ralph Lasta
- Analyst for Equity ETFs
- Joined VanEck in 2019
- Prior to VanEck, Intermediate Representative, Exchange Traded Funds at BNY Mellon.
- BS, Accounting, Hunter College
Prices as of 03/05/21
Performance History: Average Annual Total Returns* (%)
1 MO | 3 MO | YTD | 1 YR | 3 YR | 5 YR | 10 YR | LIFE 12/20/11 |
|
---|---|---|---|---|---|---|---|---|
PPH (NAV) | -1.01 | 4.06 | 1.87 | 16.19 | 7.24 | 5.32 | -- | 9.31 |
PPH (Share Price) | -0.90 | 4.24 | 2.00 | 16.46 | 7.29 | 5.34 | -- | 9.45 |
MVPPHTR (Index) | -1.03 | 3.97 | 1.44 | 15.84 | 7.03 | 5.22 | -- | 9.22 |
Performance Differential (NAV - Index) | 0.02 | 0.09 | 0.43 | 0.35 | 0.21 | 0.10 | -- | 0.09 |
1 MO | 3 MO | YTD | 1 YR | 3 YR | 5 YR | 10 YR | LIFE 12/20/11 |
|
---|---|---|---|---|---|---|---|---|
PPH (NAV) | 2.15 | 7.47 | 5.20 | 5.20 | 5.74 | 2.33 | -- | 9.26 |
PPH (Share Price) | 2.20 | 7.35 | 5.33 | 5.33 | 5.77 | 2.32 | -- | 9.38 |
MVPPHTR (Index) | 2.49 | 7.80 | 4.96 | 4.96 | 5.60 | 2.26 | -- | 9.22 |
Performance Differential (NAV - Index) | -0.34 | -0.33 | 0.24 | 0.24 | 0.14 | 0.07 | -- | 0.04 |
Top 10 Holdings (%) as of 02/28/21 Daily Holdings
to view
full data
Holding Name |
Ticker
|
Shares |
Market Value (US$) |
% of Net Assets |
|
---|---|---|---|---|---|
ELI LILLY AND CO |
LLY US
|
56,332
|
11,541,863 | 6.49 | |
CATALENT INC |
CTLT US
|
86,778
|
9,867,526 | 5.55 | |
JOHNSON & JOHNSON |
JNJ US
|
58,136
|
9,212,231 | 5.18 | |
BRISTOL-MYERS SQUIBB CO |
BMY US
|
146,104
|
8,960,558 | 5.04 | |
ABBVIE INC |
ABBV US
|
81,908
|
8,824,768 | 4.96 | |
NOVARTIS AG |
NVS US
|
97,159
|
8,346,930 | 4.69 | |
SANOFI |
SNY US
|
179,414
|
8,233,308 | 4.63 | |
TEVA PHARMACEUTICAL INDUSTRIES LTD |
TEVA US
|
752,173
|
8,093,381 | 4.55 | |
BAUSCH HEALTH COS INC |
BHC US
|
257,389
|
8,087,162 | 4.55 | |
AMERISOURCEBERGEN CORP |
ABC US
|
79,226
|
8,019,256 | 4.51 | |
Top 10 Total (%) | 50.15 |
Country Weightings (%) as of 02/28/21
-
Country
% of Net Assets -
■
United States
66.68 -
■
United Kingdom
10.28 -
■
Switzerland
4.69 -
■
France
4.63 -
■
Israel
4.55 -
■
Japan
4.03 -
■
Denmark
3.95 -
■
Ireland
1.28 -
■
Other/Cash
-0.09
Sector Weightings (%) as of 02/28/21
-
Sector
% of Net Assets -
■
Health Care
100.1 -
■
Other/Cash
-0.1